Australia’s youngest next to receive COVID-19 vaccine

With the COVID-19 vaccine for children aged 6 months to 5 years given the green light in the United States, Moderna’s Chief Medical Officer Dr Paul Burton expects the infant vaccine to roll out in Australia next month.

Updated heart failure and atrial fibrillation guidelines

New guidelines on heart failure and atrial fibrillation have been released, including new pharmacological recommendations. Released by the National Heart Foundation of Australia (NHF) in...

A preventable tragedy that changed drug approval forever

Thalidomide’s period of use may have been short but its ramifications have lasted decades, both for people who suffer deformities from its effects and...

The policymaker

Karen Castle MPS, PSA’s newest policy pharmacist, writes healthcare legislation and knows plenty about voluntary assisted dying requirements.

Comorbid insomnia and sleep apnoea (COMISA)

Comorbid insomnia and sleep apnoea is a debilitating condition that requires nuanced assessment and management approaches.

The hidden toll of ‘good enough’ asthma control

Parents have reported persistent anxiety about asthma attacks. Pharmacists can help to pivot care from treating flare-ups to stopping them.